JP2016524592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016524592A5 JP2016524592A5 JP2016509455A JP2016509455A JP2016524592A5 JP 2016524592 A5 JP2016524592 A5 JP 2016524592A5 JP 2016509455 A JP2016509455 A JP 2016509455A JP 2016509455 A JP2016509455 A JP 2016509455A JP 2016524592 A5 JP2016524592 A5 JP 2016524592A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- icosl
- specific antigen
- binding molecule
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361815043P | 2013-04-23 | 2013-04-23 | |
| US61/815,043 | 2013-04-23 | ||
| PCT/EP2014/058276 WO2014173975A1 (en) | 2013-04-23 | 2014-04-23 | Isolation of therapeutic target specific vnar domains to icosl |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016524592A JP2016524592A (ja) | 2016-08-18 |
| JP2016524592A5 true JP2016524592A5 (OSRAM) | 2017-06-01 |
| JP6591964B2 JP6591964B2 (ja) | 2019-10-16 |
Family
ID=50543598
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016509455A Active JP6591964B2 (ja) | 2013-04-23 | 2014-04-23 | Ｉｃｏｓｌへの治療上の標的特異的ｖｎａｒドメインの単離 |
| JP2016509450A Active JP6616284B2 (ja) | 2013-04-23 | 2014-04-23 | 特異的結合分子の人工ライブラリー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016509450A Active JP6616284B2 (ja) | 2013-04-23 | 2014-04-23 | 特異的結合分子の人工ライブラリー |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10202438B2 (OSRAM) |
| EP (3) | EP3683312B1 (OSRAM) |
| JP (2) | JP6591964B2 (OSRAM) |
| KR (2) | KR102320189B1 (OSRAM) |
| CN (2) | CN105492610B (OSRAM) |
| AU (3) | AU2014257549B2 (OSRAM) |
| BR (2) | BR112015026716A2 (OSRAM) |
| CA (2) | CA2909921C (OSRAM) |
| DK (1) | DK2989203T3 (OSRAM) |
| RU (2) | RU2015146419A (OSRAM) |
| WO (2) | WO2014173975A1 (OSRAM) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013167883A1 (en) | 2012-05-07 | 2013-11-14 | The University Court Of The University Of Aberdeen | Single domain binding molecule |
| KR102320189B1 (ko) | 2013-04-23 | 2021-11-03 | 엘라스모겐 리미티드 | 특이적 결합 분자의 합성 라이브러리 |
| WO2015200883A2 (en) * | 2014-06-26 | 2015-12-30 | Ossianix, Inc. | Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds |
| JP6734271B2 (ja) * | 2014-11-03 | 2020-08-05 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 二重特異性サメ抗体可変ドメインの製造方法およびそれらの使用 |
| CA2967830A1 (en) | 2014-11-14 | 2016-05-19 | Ossianix, Inc. | Tfr selective binding compounds and related methods |
| ITUB20151014A1 (it) * | 2015-05-27 | 2016-11-27 | Univ Degli Studi Del Piemonte Orientale Amedeo Avogadro | Ligandi del recettore b7h nel trattamento di osteopenia e osteoporosi |
| KR102824067B1 (ko) | 2016-04-15 | 2025-06-23 | 알파인 이뮨 사이언시즈, 인코포레이티드 | Icos 리간드 변이체 면역조절 단백질 및 그의 용도 |
| CN107130300A (zh) * | 2016-10-08 | 2017-09-05 | 深圳劲宇生物科技有限公司 | 一种dna编码分子库的合成方法及dna模板 |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| WO2019063726A1 (en) | 2017-09-27 | 2019-04-04 | Elasmogen Ltd | SPECIFIC BINDING MOLECULES |
| US11180544B2 (en) * | 2017-11-07 | 2021-11-23 | City University Of Hong Kong | Method of producing antibody fragment |
| GB201721802D0 (en) | 2017-12-22 | 2018-02-07 | Almac Discovery Ltd | Ror1-specific antigen binding molecules |
| WO2020056327A1 (en) | 2018-09-14 | 2020-03-19 | Ossianix, Inc. | Tfr-specific binding moieties and transcytosis method to select vnars that cross cellular barriers |
| CN111197074B (zh) * | 2018-11-20 | 2023-08-15 | 深圳华大生命科学研究院 | 条纹斑竹鲨免疫球蛋白新抗原受体可变区库引物及应用 |
| US20220130494A1 (en) * | 2019-02-11 | 2022-04-28 | Neal W. Woodbury | Systems, methods, and media for molecule design using machine learning mechanisms |
| GB201906997D0 (en) * | 2019-05-17 | 2019-07-03 | Elasmogen Ltd | Conjugates |
| GB201908886D0 (en) * | 2019-06-20 | 2019-08-07 | Almac Discovery Ltd | Anthracycline derivatives |
| CN116457368A (zh) * | 2020-05-01 | 2023-07-18 | 匹兹堡大学联邦高等教育系统 | 用于鉴定纳米抗体和纳米抗体亲和力的组合物和方法 |
| CN112301431B (zh) * | 2020-08-12 | 2023-01-31 | 华东理工大学 | 基于鲨鱼抗体可变区v-nar的噬菌体文库及其构建方法 |
| GB202020154D0 (en) * | 2020-12-18 | 2021-02-03 | Almac Discovery Ltd | ROR1-specific variant antigen binding molecules |
| GB202020152D0 (en) | 2020-12-18 | 2021-02-03 | Elasmogen Ltd | Fast-track humanisation of specific binding molecules |
| WO2022212429A1 (en) * | 2021-03-31 | 2022-10-06 | Sachdev Sidhu | Anti-viral compositions for rift valley fever virus infections and methods of using same |
| EP4141028A1 (en) | 2021-08-31 | 2023-03-01 | Johann-Wolfgang-Goethe-Universität Frankfurt am Main | Personalized vnar-based chimeric antigen receptors (vnar-car) for the treatment of clonal b-and t cell malignancies, and methods for producing vnar-cars |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0008419D0 (en) | 2000-04-05 | 2000-05-24 | Bioinvent Int Ab | A method for invitro molecular evolution of antibody function |
| CA2457636C (en) * | 2001-08-10 | 2012-01-03 | Aberdeen University | Antigen binding domains |
| CA2488441C (en) | 2002-06-03 | 2015-01-27 | Genentech, Inc. | Synthetic antibody phage libraries |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| US20050048617A1 (en) * | 2003-08-18 | 2005-03-03 | Medimmune, Inc. | Humanization of antibodies |
| DE602004032042D1 (de) * | 2003-08-27 | 2011-05-12 | Proterec Ltd | Bibliotheken rekombinanter chimärischer proteine |
| CA2567655C (en) * | 2004-06-02 | 2015-06-30 | Diatech Pty Ltd | Binding moieties based on shark ignar domains |
| ES2526343T3 (es) * | 2004-06-03 | 2015-01-09 | Novimmune Sa | Anticuerpos anti-CD3 y métodos de uso de los mismos |
| WO2006003999A1 (ja) * | 2004-07-05 | 2006-01-12 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | ヒト抗ヒトb7rp-1抗体およびその抗体フラグメント |
| WO2006102095A2 (en) * | 2005-03-18 | 2006-09-28 | Medimmune, Inc. | Framework-shuffling of antibodies |
| ES2558338T3 (es) | 2005-03-25 | 2016-02-03 | National Research Council Of Canada | Método para aislamiento de polipéptidos solubles |
| CN103254309B (zh) | 2005-05-18 | 2017-09-26 | 埃博灵克斯股份有限公司 | 针对肿瘤坏死因子α的改进的纳米体TM |
| CA2854576A1 (en) | 2005-07-18 | 2007-01-25 | Haichun Huang | Human anti-b7rp1 neutralizing antibodies |
| AU2007293614A1 (en) | 2006-09-08 | 2008-03-13 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
| ATE536369T1 (de) | 2006-10-11 | 2011-12-15 | Ablynx Nv | Im wesentlichen ph-wert-unabhängigerweise an serumproteine bindende aminosäuresequenzen, verbindungen, die diese enthalten, und deren verwendung |
| WO2009026638A1 (en) | 2007-08-31 | 2009-03-05 | Melbourne Health | Marine-animal derived therapeutic and diagnostic agents for hepatitis b |
| EP2344545A4 (en) * | 2008-10-06 | 2012-10-03 | Commw Scient Ind Res Org | CRYSTALLINE STRUCTURE OF BETA-AMYLOID PEPTIDE |
| BRPI0920810A2 (pt) * | 2008-10-07 | 2015-12-22 | Zap Holdings Ltd | sincronização de bancos de dados relacionais com cubos de olap |
| WO2011056056A2 (es) | 2009-11-04 | 2011-05-12 | Laboratorios Silanes, S.A. De C.V. | Dominios vhnar anti -citocinas |
| EP2646461A2 (en) * | 2010-12-03 | 2013-10-09 | Cyclogenix Ltd | VARIANTS OF igNAR |
| WO2013167883A1 (en) * | 2012-05-07 | 2013-11-14 | The University Court Of The University Of Aberdeen | Single domain binding molecule |
| CN103031304A (zh) * | 2012-12-27 | 2013-04-10 | 苏州大学 | 一种微小rna用于调控b7-h2基因表达 |
| KR102320189B1 (ko) | 2013-04-23 | 2021-11-03 | 엘라스모겐 리미티드 | 특이적 결합 분자의 합성 라이브러리 |
-
2014
- 2014-04-23 KR KR1020157033430A patent/KR102320189B1/ko active Active
- 2014-04-23 EP EP19208141.2A patent/EP3683312B1/en active Active
- 2014-04-23 WO PCT/EP2014/058276 patent/WO2014173975A1/en not_active Ceased
- 2014-04-23 EP EP14720559.5A patent/EP2989204B1/en active Active
- 2014-04-23 CN CN201480035865.XA patent/CN105492610B/zh active Active
- 2014-04-23 EP EP14718999.7A patent/EP2989203B1/en active Active
- 2014-04-23 CN CN201480035842.9A patent/CN105531370A/zh active Pending
- 2014-04-23 RU RU2015146419A patent/RU2015146419A/ru not_active Application Discontinuation
- 2014-04-23 JP JP2016509455A patent/JP6591964B2/ja active Active
- 2014-04-23 AU AU2014257549A patent/AU2014257549B2/en active Active
- 2014-04-23 US US14/786,074 patent/US10202438B2/en active Active
- 2014-04-23 WO PCT/EP2014/058251 patent/WO2014173959A2/en not_active Ceased
- 2014-04-23 CA CA2909921A patent/CA2909921C/en active Active
- 2014-04-23 US US14/785,975 patent/US10472410B2/en active Active
- 2014-04-23 JP JP2016509450A patent/JP6616284B2/ja active Active
- 2014-04-23 CA CA2909923A patent/CA2909923A1/en not_active Abandoned
- 2014-04-23 AU AU2014257565A patent/AU2014257565A1/en not_active Abandoned
- 2014-04-23 BR BR112015026716A patent/BR112015026716A2/pt not_active IP Right Cessation
- 2014-04-23 RU RU2015146418A patent/RU2015146418A/ru not_active Application Discontinuation
- 2014-04-23 BR BR112015026729A patent/BR112015026729A2/pt not_active Application Discontinuation
- 2014-04-23 DK DK14718999.7T patent/DK2989203T3/da active
- 2014-04-23 KR KR1020157033307A patent/KR20160010466A/ko not_active Withdrawn
-
2019
- 2019-02-11 US US16/271,959 patent/US11459377B2/en active Active
- 2019-07-18 AU AU2019206064A patent/AU2019206064A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016524592A5 (OSRAM) | ||
| JP7453206B2 (ja) | 改良された血清アルブミン結合剤 | |
| RU2015146419A (ru) | Выделение терапевтических доменов vnar, специфичных по отношению к мишени icosl | |
| JP2023027258A (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| TWI604851B (zh) | Ｉｌ－１７抗體用於製備治療強直性脊椎炎之藥物之用途 | |
| JP2011521662A5 (OSRAM) | ||
| CN108473563B (zh) | 改进的tnf结合剂 | |
| US20170081412A1 (en) | Antibody-fynomer conjugates | |
| JP2019533807A5 (OSRAM) | ||
| CN109937212A (zh) | B7-h3抗体、其抗原结合片段及其医药用途 | |
| JP2012518425A5 (OSRAM) | ||
| US20250154255A1 (en) | DOSING REGIMEN FOR BCMAx-CD3 ANTIBODIES CONSTRUCTS | |
| US20210260113A1 (en) | Devices, methods, compositions and systems for the treatment of aging and age-related disorders | |
| JP2017522903A5 (OSRAM) | ||
| JP2018529634A5 (OSRAM) | ||
| JP2016524463A5 (OSRAM) | ||
| JP2012518398A5 (OSRAM) | ||
| JP2018537421A5 (OSRAM) | ||
| TW200808821A (en) | Antibody purification | |
| TW201333033A (zh) | 雙可變域免疫球蛋白及其用途 | |
| RU2016135962A (ru) | Выделенное антитело, способ его получения, выделенная нуклеиновая кислота, экспрессионная кассета, клетка-хозяин, фармацевтический и диагностический препараты, способ лечения больного, подверженного риску или страдающего от инфекции E.COLI, и способ диагностики определения инфекций E.COLI | |
| JP2021512159A5 (OSRAM) | ||
| JP2017515473A5 (OSRAM) | ||
| BR112021006123A2 (pt) | anticorpos anti-sinucleína | |
| US20250136704A1 (en) | Methods for administering a bcmaxcd3 binding molecule |